These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 21543761)
1. Development and characterization of APRIL antagonistic monoclonal antibodies for treatment of B-cell lymphomas. Guadagnoli M; Kimberley FC; Phan U; Cameron K; Vink PM; Rodermond H; Eldering E; Kater AP; van Eenennaam H; Medema JP Blood; 2011 Jun; 117(25):6856-65. PubMed ID: 21543761 [TBL] [Abstract][Full Text] [Related]
2. Unique and redundant roles of mouse BCMA, TACI, BAFF, APRIL, and IL-6 in supporting antibody-producing cells in different tissues. Eslami M; Schuepbach-Mallepell S; Diana D; Willen L; Kowalczyk-Quintas C; Desponds C; Peter B; Vigolo M; Renevey F; Donzé O; Luther SA; Yalkinoglu Ö; Alouche N; Schneider P Proc Natl Acad Sci U S A; 2024 Jul; 121(29):e2404309121. PubMed ID: 38990948 [TBL] [Abstract][Full Text] [Related]
4. TACI regulates IgA production by APRIL in collaboration with HSPG. Sakurai D; Hase H; Kanno Y; Kojima H; Okumura K; Kobata T Blood; 2007 Apr; 109(7):2961-7. PubMed ID: 17119122 [TBL] [Abstract][Full Text] [Related]
5. The BAFF/APRIL system: emerging functions beyond B cell biology and autoimmunity. Vincent FB; Saulep-Easton D; Figgett WA; Fairfax KA; Mackay F Cytokine Growth Factor Rev; 2013 Jun; 24(3):203-15. PubMed ID: 23684423 [TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in genes of the BAFF/APRIL system may constitute risk factors of B-CLL--a preliminary study on a Polish population. Jasek M; Wagner M; Sobczynski M; Wolowiec D; Kuliczkowski K; Woszczyk D; Kielbinski M; Kusnierczyk P; Frydecka I; Karabon L Tissue Antigens; 2015 Oct; 86(4):279-84. PubMed ID: 26268376 [TBL] [Abstract][Full Text] [Related]
7. The proteoglycan (heparan sulfate proteoglycan) binding domain of APRIL serves as a platform for ligand multimerization and cross-linking. Kimberley FC; van Bostelen L; Cameron K; Hardenberg G; Marquart JA; Hahne M; Medema JP FASEB J; 2009 May; 23(5):1584-95. PubMed ID: 19141538 [TBL] [Abstract][Full Text] [Related]
8. TACI-dependent APRIL signaling maintains autoreactive B cells in a mouse model of systemic lupus erythematosus. Tran NL; Schneider P; Santiago-Raber ML Eur J Immunol; 2017 Apr; 47(4):713-723. PubMed ID: 28267197 [TBL] [Abstract][Full Text] [Related]
9. Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL. Chiu A; Xu W; He B; Dillon SR; Gross JA; Sievers E; Qiao X; Santini P; Hyjek E; Lee JW; Cesarman E; Chadburn A; Knowles DM; Cerutti A Blood; 2007 Jan; 109(2):729-39. PubMed ID: 16960154 [TBL] [Abstract][Full Text] [Related]
10. Deficient TACI expression on B lymphocytes of newborn mice leads to defective Ig secretion in response to BAFF or APRIL. Kanswal S; Katsenelson N; Selvapandiyan A; Bram RJ; Akkoyunlu M J Immunol; 2008 Jul; 181(2):976-90. PubMed ID: 18606649 [TBL] [Abstract][Full Text] [Related]
11. APRIL is overexpressed in cancer: link with tumor progression. Moreaux J; Veyrune JL; De Vos J; Klein B BMC Cancer; 2009 Mar; 9():83. PubMed ID: 19291294 [TBL] [Abstract][Full Text] [Related]
12. Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease. Rickert RC; Jellusova J; Miletic AV Immunol Rev; 2011 Nov; 244(1):115-33. PubMed ID: 22017435 [TBL] [Abstract][Full Text] [Related]
13. BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway. Endo T; Nishio M; Enzler T; Cottam HB; Fukuda T; James DF; Karin M; Kipps TJ Blood; 2007 Jan; 109(2):703-10. PubMed ID: 16973958 [TBL] [Abstract][Full Text] [Related]
14. The role of the BAFF/APRIL system in the T cell-independent specific response to blood stage Plasmodium falciparum hemozoin. Dechkajorn W; Benjathummarak S; Kumsiri R; Maneerat Y Cytokine; 2018 Nov; 111():445-453. PubMed ID: 29884307 [TBL] [Abstract][Full Text] [Related]
15. Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen. Schneider P; Takatsuka H; Wilson A; Mackay F; Tardivel A; Lens S; Cachero TG; Finke D; Beermann F; Tschopp J J Exp Med; 2001 Dec; 194(11):1691-7. PubMed ID: 11733583 [TBL] [Abstract][Full Text] [Related]
16. BAFF, APRIL and their receptors: structure, function and signaling. Bossen C; Schneider P Semin Immunol; 2006 Oct; 18(5):263-75. PubMed ID: 16914324 [TBL] [Abstract][Full Text] [Related]
17. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA. Day ES; Cachero TG; Qian F; Sun Y; Wen D; Pelletier M; Hsu YM; Whitty A Biochemistry; 2005 Feb; 44(6):1919-31. PubMed ID: 15697217 [TBL] [Abstract][Full Text] [Related]
18. Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL. He B; Chadburn A; Jou E; Schattner EJ; Knowles DM; Cerutti A J Immunol; 2004 Mar; 172(5):3268-79. PubMed ID: 14978135 [TBL] [Abstract][Full Text] [Related]
19. B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses. Xu S; Lam KP Mol Cell Biol; 2001 Jun; 21(12):4067-74. PubMed ID: 11359913 [TBL] [Abstract][Full Text] [Related]